Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SGMTSagimet Biosciences Inc.

Nasdaq · CIK 0001400118
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts176

Identity from submissions API

NameSagimet Biosciences Inc.
CIK0001400118
TickersSGMT
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN205991472
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 561-8600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • 3-V Biosciences, Inc. (2007-05-08T04:00:00.000Z → 2019-02-25T05:00:00.000Z)
Business address
950 TOWER LANE
STE 1500
FOSTER CITY
CA
94404
CA
Mailing address
950 TOWER LANE
STE 1500
FOSTER CITY
CA
94404
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

267 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-008060 005-94156 261559158 34 9114
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005057 005-94156 261555133 34 15267
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127339 005-94156 261554774 34 11096
2026-11-12 8-K 8-K 2.02,7.01,9.01 0001193125-26-457000 001-41742 261543327 34 13374711 1 1
2026-11-12 10-Q 10-Q 0001193125-26-456948 001-41742 261543209 34 9389960 1 1
2026-10-22 8-K 8-K 7.01,9.01 0001193125-26-428314 001-41742 261477214 34 4260611 1 1
2026-10-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000045 005-94156 261447913 34 15631
2026-10-01 8-K 8-K 1.01,9.01 0001193125-26-409335 001-41742 261428321 34 529999 1 1
2026-10-01 424B5 424B5 0001193125-26-409325 333-281582 261428306 33 680966
2026-09-30 8-K 8-K 7.01,8.01,9.01 0001193125-26-408224 001-41742 261425431 34 11965900 1 1
2026-09-30 424B3 424B3 0001193125-26-408210 333-281582 261425415 33 18907
2026-08-17 4 4 0001193125-26-354018 12413
2026-08-14 144 xsl144X01/primary_doc.xml 0001950047-26-008152 001-41742 261282762 33 6538
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003438 005-94156 261275850 34 15183
2026-08-13 8-K 8-K 8.01 0001193125-26-347854 001-41742 261269984 34 143736 1 1
2026-08-12 4 4 0001193125-26-347407 12395
2026-08-11 144 xsl144X01/primary_doc.xml 0001950047-26-007964 001-41742 261263780 33 5587
2026-08-11 8-K 8-K 2.02,7.01,9.01 0001193125-26-343446 001-41742 261260631 34 3301875 1 1
2026-08-11 10-Q 10-Q 0001193125-26-343441 001-41742 261260623 34 8968153 1 1
2026-07-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003143 005-94156 261221160 34 10932
2026-07-22 4 4 0001193125-26-312397 5480
2026-07-22 4 4 0001193125-26-312394 5482
2026-07-22 4 4 0001193125-26-312386 5302
2026-07-21 8-K 8-K 7.01,9.01 0001193125-26-309334 001-41742 261188020 34 9537520 1 1
2026-07-20 144 xsl144X01/primary_doc.xml 0001950047-26-007226 001-41742 261186982 33 4929
2026-06-15 4 OWNERSHIP DOCUMENT 0001104659-26-074055 5707
2026-06-15 4 OWNERSHIP DOCUMENT 0001104659-26-074052 5727
2026-06-15 4 OWNERSHIP DOCUMENT 0001104659-26-074050 5732
2026-06-15 4 OWNERSHIP DOCUMENT 0001104659-26-074047 5690
2026-06-15 4 OWNERSHIP DOCUMENT 0001104659-26-074045 5723
2026-06-15 4 OWNERSHIP DOCUMENT 0001104659-26-074044 5725
2026-06-12 8-K FORM 8-K 5.02,5.07 0001104659-26-073431 001-41742 261086630 34 200756 1 1
2026-06-03 8-K FORM 8-K 5.02,9.01 0001104659-26-070126 001-41742 261061190 34 242033 1 1
2026-06-01 4 OWNERSHIP DOCUMENT 0001104659-26-069124 5751
2026-06-01 4 OWNERSHIP DOCUMENT 0001104659-26-069123 5758
2026-06-01 4 OWNERSHIP DOCUMENT 0001104659-26-069122 5745
2026-06-01 4 OWNERSHIP DOCUMENT 0001104659-26-069121 5719
2026-05-14 4 OWNERSHIP DOCUMENT 0001104659-26-061327 5809
2026-05-14 3 OWNERSHIP DOCUMENT 0001104659-26-061323 10910
2026-05-12 8-K FORM 8-K 2.02,9.01 0001104659-26-059009 001-41742 26965891 34 254510 1 1
2026-05-12 10-Q 10-Q 0001104659-26-059006 001-41742 26965883 34 5690106 1 1
2026-04-28 8-K FORM 8-K 1.01,9.01 0001104659-26-049756 001-41742 26903078 34 475693 1 1
2026-04-28 424B5 424B5 0001104659-26-049662 333-281582 26902947 33 707584
2026-04-27 8-K FORM 8-K 7.01,9.01 0001104659-26-049015 001-41742 26896507 34 4770504 1 1
2026-04-27 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001104659-26-048971 001-41742 26896461 34 4865156 1 1
2026-04-21 ARS ARS 0001104659-26-046015 001-41742 26879620 34 3655356
2026-04-21 DEF 14A DEF 14A 0001104659-26-046006 001-41742 26879532 34 2684719 1 1
2026-04-21 8-K FORM 8-K 5.02,8.01 0001104659-26-045629 001-41742 26876633 34 194375 1 1
2026-03-11 S-8 FORM S-8 0001104659-26-026154 333-294200 26741572 33 212564 1 1
2026-03-11 S-8 FORM S-8 0001104659-26-026152 333-294199 26741566 33 211763 1 1
2026-03-11 8-K FORM 8-K 2.02,7.01,9.01 0001104659-26-026146 001-41742 26741558 34 19833102 1 1
2026-03-11 10-K 10-K 0001104659-26-026140 001-41742 26741545 34 11844938 1 1
2026-02-20 4 OWNERSHIP DOCUMENT 0001104659-26-018196 7576
2026-02-20 4 OWNERSHIP DOCUMENT 0001104659-26-018194 7560
2026-02-20 4 OWNERSHIP DOCUMENT 0001104659-26-018193 7551
2026-02-20 4 OWNERSHIP DOCUMENT 0001104659-26-018191 7584
2026-02-12 4 OWNERSHIP DOCUMENT 0001104659-26-014283 4998
2026-02-12 4 OWNERSHIP DOCUMENT 0001104659-26-014277 5031
2026-02-12 4 OWNERSHIP DOCUMENT 0001104659-26-014272 5007
2026-02-12 4 OWNERSHIP DOCUMENT 0001104659-26-014266 5023
2026-02-02 8-K FORM 8-K 7.01,9.01 0001104659-26-008925 001-41742 26585673 34 11189592 1 1
2025-12-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-122583 005-94156 251583727 34 8609
2025-12-18 8-K FORM 8-K 7.01,8.01,9.01 0001104659-25-122272 001-41742 251581247 34 12242211 1 1
2025-12-17 8-K FORM 8-K 8.01,9.01 0001104659-25-121819 001-41742 251577234 34 263189 1 1
2025-11-21 4 OWNERSHIP DOCUMENT 0001104659-25-115071 5399
2025-11-20 144 xsl144X01/primary_doc.xml 0001950047-25-009150 001-41742 251503327 33 4898
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005028 005-94156 251486496 34 8931
2025-11-13 8-K FORM 8-K 2.02,7.01,9.01 0001104659-25-110852 001-41742 251475434 34 12338057 1 1
2025-11-13 10-Q 10-Q 0001104659-25-110846 001-41742 251475411 34 6723313 1 1
2025-11-06 4 OWNERSHIP DOCUMENT 0001104659-25-107806 7750
2025-10-23 8-K FORM 8-K 7.01,9.01 0001104659-25-101819 001-41742 251413066 34 9797108 1 1
2025-08-22 8-K FORM 8-K 4.01,9.01 0001104659-25-081630 001-41742 251242234 34 203644 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003696 005-94156 251220760 34 11179
2025-08-14 8-K FORM 8-K 1.01,1.02,9.01 0001104659-25-078752 001-41742 251220735 34 508155 1 1
2025-08-14 424B5 424B5 0001104659-25-078746 333-281582 251220608 33 539075
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003593 005-94156 251216127 34 8752
2025-08-13 8-K FORM 8-K 2.02,7.01,9.01 0001104659-25-077200 001-41742 251209008 34 12245030 1 1
2025-08-13 10-Q 10-Q 0001558370-25-011301 001-41742 251208998 34 7850417 1 1
2025-07-23 4 OWNERSHIP DOCUMENT 0001104659-25-070017 5000
2025-07-23 4 OWNERSHIP DOCUMENT 0001104659-25-070015 5009
2025-07-23 4 OWNERSHIP DOCUMENT 0001104659-25-070013 5017
2025-06-24 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002069316-25-000001 005-94156 251067224 34 8520
2025-06-10 4 OWNERSHIP DOCUMENT 0001104659-25-058226 5550
2025-06-10 4 OWNERSHIP DOCUMENT 0001104659-25-058225 7954
2025-06-10 4 OWNERSHIP DOCUMENT 0001104659-25-058224 5587
2025-06-10 4 OWNERSHIP DOCUMENT 0001104659-25-058223 5585
2025-06-10 4 OWNERSHIP DOCUMENT 0001104659-25-058222 5594
2025-06-10 4 OWNERSHIP DOCUMENT 0001104659-25-058221 5589
2025-06-10 4 OWNERSHIP DOCUMENT 0001104659-25-058220 5552
2025-06-10 8-K FORM 8-K 5.02,5.07 0001104659-25-058201 001-41742 251038031 34 208387 1 1
2025-06-04 8-K FORM 8-K 7.01,9.01 0001104659-25-056160 001-41742 251021821 34 260678 1 1
2025-05-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-075482 005-94156 25970552 34 64261
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002414 005-94156 25953986 34 12410
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-25-000364 005-94156 25940314 34 70745 1 1
2025-05-08 8-K FORM 8-K 2.02,8.01,9.01 0001104659-25-045791 001-41742 25923645 34 7458599 1 1
2025-05-08 10-Q 10-Q 0001558370-25-006836 001-41742 25923618 34 5654980 1 1
2025-05-07 UPLOAD filename1.pdf 0000000000-25-004809 001-41742 39715
2025-05-05 CORRESP filename1.htm 0001104659-25-044610 38856
2025-04-30 8-K FORM 8-K 5.02 0001104659-25-042566 001-41742 25895882 34 199975 1 1
2025-04-30 ARS ARS 0001104659-25-042563 001-41742 25895860 34 3553114
2025-04-30 DEF 14A DEF 14A 0001104659-25-042560 001-41742 25895840 34 2752196 1 1
2025-04-22 UPLOAD filename1.pdf 0000000000-25-004243 001-41742 43010
2025-03-12 S-8 FORM S-8 0001104659-25-022794 333-285732 25730082 33 99825
2025-03-12 S-8 FORM S-8 0001104659-25-022790 333-285731 25730081 33 99533
2025-03-12 8-K FORM 8-K 2.02,8.01,9.01 0001104659-25-022763 001-41742 25730004 34 6907171 1 1
2025-03-12 10-K 10-K 0001558370-25-002747 001-41742 25729998 34 11733485 1 1
2025-03-11 8-K FORM 8-K 8.01,9.01 0001104659-25-022423 001-41742 25725905 34 228297 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-004894 005-94156 25630761 34 7082
2025-02-14 8-K FORM 8-K 8.01,9.01 0001104659-25-014099 001-41742 25628959 34 8223284 1 1
2025-02-07 4 OWNERSHIP DOCUMENT 0001104659-25-010589 7568
2025-02-07 4 OWNERSHIP DOCUMENT 0001104659-25-010587 7559
2025-02-07 4 OWNERSHIP DOCUMENT 0001104659-25-010586 7575
2025-02-07 4 OWNERSHIP DOCUMENT 0001104659-25-010584 7589
2025-01-02 8-K FORM 8-K 8.01,9.01 0001104659-25-000137 001-41742 25500271 34 7291860 1 1
2024-11-14 SC 13G/A SAGIMET BIOSCIENCES INC. 0000902664-24-006666 005-94156 241465331 34 56140
2024-11-14 SC 13G SC 13G 0001140361-24-046972 005-94156 241464095 34 50934
2024-11-14 SC 13G/A SAGIMET BIOSCIENCES INC. 0000902664-24-006615 005-94156 241463209 34 42786
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118999 005-94156 241462992 34 88323
2024-11-14 8-K FORM 8-K 2.02,9.01 0001104659-24-118342 001-41742 241457315 34 311753 1 1
2024-11-14 10-Q 10-Q 0001558370-24-015623 001-41742 241457288 34 6364589 1 1
2024-08-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-26 16:01:00 9999999995-24-002642 333-281582 241243103 33 1829
2024-08-22 CORRESP filename1.htm 0001104659-24-091986 8474
2024-08-19 UPLOAD filename1.pdf 0000000000-24-009477 333-281582 40122
2024-08-16 8-K FORM 8-K 1.01,9.01 0001104659-24-090546 001-41742 241217347 34 206289 1 1
2024-08-15 S-3 S-3 0001104659-24-090180 333-281582 241213499 33 1284107
2024-08-14 8-K FORM 8-K 2.02,8.01,9.01 0001104659-24-089340 001-41742 241204273 34 6334876 1 1
2024-08-14 10-Q 10-Q 0001558370-24-012136 001-41742 241204244 34 6455165 1 1
2024-08-05 4 OWNERSHIP DOCUMENT 0001104659-24-085820 5610
2024-08-05 4 OWNERSHIP DOCUMENT 0001104659-24-085818 5603
2024-08-05 3 OWNERSHIP DOCUMENT 0001104659-24-085816 10935
2024-08-05 3 OWNERSHIP DOCUMENT 0001104659-24-085813 10671
2024-08-01 8-K FORM 8-K 5.02 0001104659-24-084645 001-41742 241164448 34 207726 1 1
2024-07-25 4 OWNERSHIP DOCUMENT 0001104659-24-082630 5409
2024-07-23 144 xsl144X01/primary_doc.xml 0001950047-24-005569 001-41742 241134727 33 4904
2024-07-23 4 OWNERSHIP DOCUMENT 0001104659-24-081892 5015
2024-07-23 4 OWNERSHIP DOCUMENT 0001104659-24-081891 5024
2024-07-23 4 OWNERSHIP DOCUMENT 0001104659-24-081887 5027
2024-07-02 8-K FORM 8-K 8.01,9.01 0001104659-24-077430 001-41742 241097176 34 13728808 1 1
2024-06-13 8-K/A FORM 8-K/A 8.01,9.01 0001104659-24-071014 001-41742 241039948 34 269710 1 1
2024-06-07 4 OWNERSHIP DOCUMENT 0001104659-24-069639 5554
2024-06-07 4 OWNERSHIP DOCUMENT 0001104659-24-069637 5459
2024-06-07 4 OWNERSHIP DOCUMENT 0001104659-24-069636 5551
2024-06-07 4 OWNERSHIP DOCUMENT 0001104659-24-069632 5593
2024-06-07 4 OWNERSHIP DOCUMENT 0001104659-24-069626 5559
2024-06-06 8-K FORM 8-K 5.07,8.01,9.01 0001104659-24-068817 001-41742 241023779 34 267358 1 1
2024-05-23 8-K FORM 8-K 7.01,9.01 0001104659-24-064509 001-41742 24975178 34 4809797 1 1
2024-05-15 8-K FORM 8-K 2.02,9.01 0001104659-24-061609 001-41742 24947256 34 267927 1 1
2024-05-15 10-Q 10-Q 0001558370-24-008205 001-41742 24947088 34 4897874 1 1
2024-05-08 4 OWNERSHIP DOCUMENT 0001104659-24-058661 5665
2024-05-08 3 OWNERSHIP DOCUMENT 0001104659-24-058657 14067
2024-05-06 8-K FORM 8-K 5.02 0001104659-24-057228 001-41742 24915645 34 208494 1 1
2024-04-18 ARS ARS 0001104659-24-048542 001-41742 24852743 34 3730928
2024-04-18 DEFA14A DEFA14A 0001104659-24-048539 001-41742 24852742 34 238455
2024-04-18 DEF 14A DEF 14A 0001104659-24-048534 001-41742 24852740 34 1686007
2024-04-03 4 OWNERSHIP DOCUMENT 0001104659-24-043264 5561
2024-04-03 4 OWNERSHIP DOCUMENT 0001104659-24-043263 5600
2024-04-03 3 OWNERSHIP DOCUMENT 0001104659-24-043262 11518
2024-04-03 3 OWNERSHIP DOCUMENT 0001104659-24-043260 11037
2024-03-28 4 OWNERSHIP DOCUMENT 0001104659-24-040517 5104
2024-03-25 S-8 FORM S-8 0001104659-24-038136 333-278196 24776858 33 87362
2024-03-25 10-K 10-K 0001558370-24-003812 001-41742 24776844 34 11299864 1 1
2024-03-25 8-K FORM 8-K 2.02,5.02,7.01,9.01 0001104659-24-038101 001-41742 24776832 34 6318447 1 1
2024-03-11 SC 13G/A filing.txt 0000315066-24-001668 005-94156 24736621 34 8351
2024-02-14 SC 13G NEW ENTERPRISE ASSOCIATES 13, L.P. / SAGIMET BIOSCIENCES -- 13G 0001072613-24-000258 005-94156 24641114 34 309078
2024-02-14 SC 13G SAGIMET BIOSCIENCES INC. 0000902664-24-001729 005-94156 24639398 34 44229
2024-02-14 SC 13G SC 13G 0001104659-24-023739 005-94156 24638769 34 92340
2024-02-14 SC 13G SC 13G 0001104659-24-022724 005-94156 24631979 34 59097
2024-02-09 SC 13G/A filing.txt 0000315066-24-001486 005-94156 24612024 34 8298
2024-02-05 SC 13G SAGIMET BIOSCIENCES INC. 0000902664-24-001054 005-94156 24596238 34 68954
2024-02-02 8-K FORM 8-K 5.02 0001104659-24-010085 001-41742 24592126 34 202066 1 1
2024-02-02 3 OWNERSHIP DOCUMENT 0001104659-24-010026 11160
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002501 12296
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002500 11615
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002499 12270
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002498 11788
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002497 6028
2024-01-30 8-K FORM 8-K 8.01,9.01 0001104659-24-008230 001-41742 24578167 34 228506 1 1
2024-01-29 424B4 S-1/A 0001104659-24-007371 333-276664 24569650 33 5178705
2024-01-25 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-01-25 16:00:00 9999999995-24-000214 333-276664 24563974 33 1828
2024-01-24 8-K FORM 8-K 2.02,9.01 0001104659-24-006042 001-41742 24554173 34 204371 1 1
2024-01-24 S-1/A S-1/A 0001104659-24-006039 333-276664 24554167 33 5337878
2024-01-23 CORRESP filename1.htm 0001104659-24-005988 13287
2024-01-23 CORRESP filename1.htm 0001104659-24-005987 6946
2024-01-23 S-1 FORM S-1 0001104659-24-005946 333-276664 24553638 33 20823859 1 1
2024-01-22 8-K FORM 8-K 7.01,8.01,9.01 0001104659-24-005399 001-41742 24547112 34 19900681 1 1
2024-01-16 UPLOAD filename1.pdf 0000000000-24-000488 377-07049 40625
2024-01-10 DRS filename1.htm 0001104659-24-003024 377-07049 24527297 33 5239024
2023-12-29 8-K FORM 8-K 5.02,7.01,9.01 0001104659-23-130486 001-41742 231527874 34 13379694 1 1
2023-12-08 4 OWNERSHIP DOCUMENT 0001104659-23-124678 5018
2023-11-21 4 OWNERSHIP DOCUMENT 0001104659-23-120377 5089
2023-11-21 4 OWNERSHIP DOCUMENT 0001104659-23-120375 5080
2023-11-21 4 OWNERSHIP DOCUMENT 0001104659-23-120374 5096
2023-11-21 4 OWNERSHIP DOCUMENT 0001104659-23-120372 5072
2023-11-21 8-K FORM 8-K 5.02 0001104659-23-120365 001-41742 231428307 34 204627 1 1
2023-11-20 4 OWNERSHIP DOCUMENT 0001104659-23-120027 5009
2023-11-13 8-K FORM 8-K 2.02,9.01 0001104659-23-116795 001-41742 231395469 34 314648 1 1
2023-11-13 10-Q 10-Q 0001558370-23-018700 001-41742 231395426 34 7491304 1 1
2023-10-23 8-K FORM 8-K 7.01,9.01 0001104659-23-110654 001-41742 231338545 34 13192712 1 1
2023-09-27 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-104304 001-41742 231285111 34 12688067 1 1
2023-09-11 SC 13G filing.txt 0000315066-23-002569 005-94156 231246751 34 8270
2023-09-08 4 OWNERSHIP DOCUMENT 0001104659-23-099310 6911
2023-08-21 8-K FORM 8-K 2.02,7.01,9.01 0001104659-23-093921 001-41742 231189213 34 6961650 1 1
2023-08-21 10-Q FORM 10-Q 0001104659-23-093910 001-41742 231189177 34 8027685 1 1
2023-08-10 8-K FORM 8-K 7.01,9.01 0001104659-23-089579 001-41742 231157276 34 13408331
2023-07-27 8-K FORM 8-K 5.02 0001104659-23-084764 001-41742 231118396 34 17919
2023-07-20 4 FORM 4 SUBMISSION 0001209191-23-042970 37048
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082737 27801
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082736 36299
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082735 15101
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082734 8000
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082732 16424
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082730 7980
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082729 32095
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082727 12510
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082726 38595
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082724 16679
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082722 7943
2023-07-20 4 OWNERSHIP DOCUMENT 0001104659-23-082720 7838
2023-07-18 8-K FORM 8-K 5.03,9.01 0001104659-23-082006 001-41742 231094303 34 257784
2023-07-17 S-8 FORM S-8 0001104659-23-081410 333-273276 231090473 33 107297
2023-07-17 424B4 424B4 0001104659-23-081319 333-272901 231090165 33 7080553
2023-07-14 SEC STAFF LETTER filename1.pdf 9999999997-23-003558 63573
2023-07-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-07-13 16:00:00 9999999995-23-002083 333-272901 231087967 33 1780
2023-07-13 3 FORM 3 SUBMISSION 0001209191-23-042248 18621
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080926 15332
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080925 23461
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080924 15828
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080922 12084
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080921 14333
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080920 12247
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080919 18273
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080918 13528
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080917 19978
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080915 11818
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080914 13874
2023-07-13 3 OWNERSHIP DOCUMENT 0001104659-23-080913 12215
2023-07-13 S-1MEF S-1MEF 0001104659-23-080883 333-273241 231087746 33 59584
2023-07-13 CERT SGMT_8-ACert.pdf 0001354457-23-000501 001-41742 231086496 34 258394
2023-07-11 8-A12B 8-A12B 0001104659-23-079973 001-41742 231082203 34 15743
2023-07-11 CORRESP filename1.htm 0001104659-23-079971 13956
2023-07-11 CORRESP filename1.htm 0001104659-23-079969 7888
2023-07-10 CORRESP filename1.htm 0001104659-23-079271 19419
2023-07-10 S-1/A S-1/A 0001104659-23-079261 333-272901 231078137 33 7674607
2023-07-06 SEC STAFF LETTER filename1.pdf 9999999997-23-003505 64817
2023-07-06 UPLOAD filename1.pdf 0000000000-23-007220 45183
2023-07-03 S-1/A S-1/A 0001104659-23-077601 333-272901 231065358 33 7921208
2023-06-23 S-1 S-1 0001104659-23-074215 333-272901 231038574 33 11448962
2023-05-15 SEC STAFF LETTER filename1.pdf 9999999997-23-002923 280288
2023-05-11 DRS/A filename1.htm 0001104659-23-058626 377-06644 23908386 33 7149989
2023-05-10 DRSLTR filename1.htm 0001104659-23-058635 19486
2023-04-25 DRSLTR filename1.htm 0001104659-23-049431 50362
2023-04-25 DRS/A filename1.htm 0001104659-23-049425 377-06644 23843051 33 7073047
2023-04-20 UPLOAD filename1.pdf 0000000000-23-003950 57238
2023-03-24 DRS filename1.htm 0001104659-23-036577 377-06644 23759639 33 8452955
2022-03-21 RW RW 0001104659-22-035782 333-255304 22754125 NE 9793
2021-05-10 S-1/A S-1/A 0001104659-21-064037 333-255304 21908614 33 6018071
2021-04-16 S-1 S-1 0001104659-21-051413 333-255304 21831895 33 7533288
2021-03-11 DRS filename1.htm 0001104659-21-034706 377-04387 21731768 33 7117450
2021-01-05 D xslFormDX01/primary_doc.xml 06b 0001400118-21-000001 021-385183 21503274 33 12478
2019-02-25 D xslFormDX01/primary_doc.xml 06b 0001400118-19-000002 021-333505 19630470 33 14322
2016-07-05 D xslFormDX01/primary_doc.xml 06b 0001400118-16-000002 021-266373 161751608 33 11576
2015-03-17 D xslFormDX01/primary_doc.xml 06b 0001400118-15-000001 021-236101 15707925 33 11544
2013-06-27 D xslFormDX01/primary_doc.xml 06 0001400118-13-000001 021-198677 13935811 33 11121
2012-12-20 D/A xslFormDX01/primary_doc.xml 06 0001400118-12-000001 021-169863 121275663 33 11011
2011-12-12 D xslFormDX01/primary_doc.xml 06 0001400118-11-000002 021-169863 111254254 33 10952
2009-07-22 D xslFormDX01/primary_doc.xml 06 0001400118-09-000004 021-103158 09955982 33 10909
2007-05-08 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-07-024645 021-103158 07054688 34 1574

Latest XBRL company facts

One latest value per concept from companyfacts (176 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 30.67M 2024-11-08 2024 Q3 10-Q 2024-11-14 0001558370-24-015623
dei EntityPublicFloat Entity Public Float USD 228.40M 2025-06-30 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 454,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 402,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001558370-24-012136
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -560,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 632.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.39M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 27,000 2024-04-01 2024-06-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 1.40M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap Assets Assets USD 282.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AssetsCurrent Assets, Current USD 240.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 560,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 32.27M 2022-12-31 2023 Q3 10-Q 2023-11-13 0001558370-23-018700
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2023-09-30 2023 Q3 10-Q 2023-11-13 0001558370-23-018700
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 110.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 110.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 275.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 110.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 75.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 6.56M 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2024-06-30 2024 Q2 10-Q 2024-08-14 0001558370-24-012136
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2022-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -44.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 10,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 77.43M 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 8.82M 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 16,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 46.66M 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.44M 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 313,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 77.41M 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 16,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 16,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 28,000 2023-12-31 2024 FY 10-K 2025-03-12 0001558370-25-002747
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 27,000 2022-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.88 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.88 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.005 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0001558370-25-002747
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -4,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-12 0001558370-25-002747
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 1,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001104659-23-093910
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 4,000 2022-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 14.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -10.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 10.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 156,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 216,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 164,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 5.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 55,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap InterestAndOtherIncome Interest and Other Income USD 5.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 164.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 80,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 80,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 80,000 2022-12-31 2023 Q3 10-Q 2023-11-13 0001558370-23-018700
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 27,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001558370-23-018700
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap Liabilities Liabilities USD 39.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 282.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap LiabilitiesCurrent Liabilities, Current USD 37.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 125.44M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 39.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 194.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -87.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -31.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -43.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap NetRentableArea Net Rentable Area sqft 7,204 2026-05-28 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OperatingExpenses Operating Expenses USD 49.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -49.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OperatingLeaseCost Operating Lease, Cost USD 215,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 78,000 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 88,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 159,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap OtherAssetsCurrent Other Assets, Current USD 302,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 55,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OtherCommitment Other Commitment USD 2.50M 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -23,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001558370-24-008205
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -680,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 13,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 5.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PaymentsForRent Payments for Rent USD 3.00M 2026-05-28 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 11.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 11.14M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 145.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap PrepaidInsurance Prepaid Insurance USD 771,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap ProceedsFromCollaborators Proceeds from Collaborators USD 1.70M 2023-08-01 2023-08-31 2024 Q3 10-Q 2024-11-14 0001558370-24-015623
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 89.68M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-12 0001558370-25-002747
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 175.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 58.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 214.62M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-12 0001558370-25-002747
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 34.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -390.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 2.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-12 0001558370-25-002747
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 89.68M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.91 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001104659-23-093910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.89 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001104659-23-093910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.03 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-21 0001104659-23-093910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.036 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001104659-23-093910
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 867,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.00M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.5 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 200,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 14,725 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 147 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 721,081 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.77 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 3.80M 2025-12-31 2026 Q2 10-Q 2026-08-11 0001193125-26-343441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.44M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.12 2025-12-31 2026 Q2 10-Q 2026-08-11 0001193125-26-343441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 1.99M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.44M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.04 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 3.78M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-21 0001104659-23-093910
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.14 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 10.1 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 23.05 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.38 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001104659-26-059006
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 242.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.013 2023-07-07 2024 FY 10-K 2025-03-12 0001558370-25-002747
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 44,792 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 93,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 163.85M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1,000 2025-04-01 2025-06-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110846
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.27M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 214.62M 2022-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 232.96M 2022-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2023-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.34M 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 151,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 306,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 11.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001104659-26-026140
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 4,000 2022-12-31 2023 FY 10-K 2024-03-25 0001558370-24-003812
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 49.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 49.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-456948

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →